AGN
ARGENICA FPO [AGN]
Healthcare · ASX Small Cap
$0.2250 +2.3%
Updated 2026-03-02 · Scores refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scans→ Score -2First seen: 2026-02-25
Score Breakdown
Technical42
Catalyst50
Sentiment50
Fundamental43
Momentum22
Risk Gate35
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Sustained volume spike (3.1x median) on DOWN trend
- Near support level (potential bounce)
- Sharp 5-day decline (-11.8%)
- Volatility contracting (breakout setup)
- Low cash runway (2 quarters) - dilution risk
- 4C filed 2026-01-27
- Revenue in sharp decline (-78%)
- Near 52-week low (4% of range)
- Small-cap ($20-100M)
- Severe 12-1 momentum decline (-64%)
- Altman Z-Score in distress zone (0.88 < 1.81)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-78%)
Recent Catalysts
NONE Half Yearly Report and Accounts
NONE Successful Applicaton for EMA Paediatric Waiver
NONE Final Director's Interest Notice
LOW Investor Presentation - Euroz Hartleys Healthcare Conference
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-02-10 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-04 | Investor Presentation - Euroz Hartleys Healthcare Conference |
| 2026-02-01 | Successful Applicaton for EMA Paediatric Waiver PRICE SENSITIVE |
| 2026-01-27 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-01-02 | Final Director's Interest Notice |
Key Metrics
$28.3M
Market Cap
110K
Avg Volume
3.1x
Vol Ratio
$0.19 — $0.86
52-Week Range
N/A
Short Interest
2 qtrs
Cash Runway
-117.8%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 72% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #105 of 119 · Sector avg: 51
View all Healthcare signals →